Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: The role of corticosterone

Neuroscience

Volumn 159, Issue 4, 2009, Pages 1233-1243

  Johnson, B N ^a   Yamamoto, B K ^a  

^a Neurochemistry Laboratory   (United States)

Author keywords

5 HT; frontal cortex; hippocampus; hyperthermia; metyrapone; striatum

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CORTICOSTERONE; DOPAMINE; METYRAPONE; MONOAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CHRONIC STRESS; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; FRONTAL CORTEX; HIPPOCAMPUS; HYPERTHERMIA; MALE; MONOAMINE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BODY TEMPERATURE; BRAIN; CORPUS STRIATUM; CORTICOSTERONE; DOPAMINE; ENZYME INHIBITORS; FEVER; FRONTAL LOBE; HIPPOCAMPUS; MALE; METYRAPONE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; STRESS, PSYCHOLOGICAL;

EID: 63349087822     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.01.067     Document Type: Article

References (78)

1. Aguirre N., Frechilla D., Garcia-Osta A., Lasheras B., and Del Rio J. Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine 1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: the role of corticosteroids. J Neurochem 68 (1997) 1099-1105
2. 3H]-paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242 (1987) 911-916
3. Broening H.W., Bowyer J.F., and Slikker Jr. W. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275 (1995) 325-333
4. Burrows K.B., Gudelsky G., and Yamamoto B.K. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur J Pharmacol 398 (2000) 11-18
5. Calvo N., Martijena I.D., Molina V.A., and Volosin M. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress. Brain Res 800 (1998) 227-235
6. Cohen G. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. Adv Neurol 45 (1987) 119-125
7. Colado M.I., O'Shea E., Granados R., Murray T.K., and Green A.R. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121 (1997) 889-900
8. Commins D.L., Yosmer G., Virus R.M., Woolverton W.L., Schuster C.R., and Seiden L.S. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241 (1987) 338-345
9. Cook M.I., and Wellman C.L. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol 60 (2004) 236-248
10. Darvesh A.S., and Gudelsky G.A. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Res 1056 (2005) 168-175
11. DeRoche V., Marinelli M., Maccari S., LeMoal M., Simon H., and Piazza P.V. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J Neurosci 15 (1995) 7181-7188
12. Erb S., Shaham Y., and Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 128 (1996) 408-412
13. Fernandez F., Aguerre S., Mormede P., and Chaouloff F. Influences of the corticotrophic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats. Eur J Neurosci 16 (2002) 607-618
14. Gehrke B.J., Harrod S.B., Cass W.A., and Bardo M.T. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats. Psychopharmacology 166 (2003) 249-257
15. Gibb J.W., Johnson M., and Hanson G.E. Neurochemical basis of neurotoxicity. Neurotoxicology 11 (1990) 317-321
16. Gluck M.R., Moy L.Y., Jayatilleke E., Hogan K.A., Manzino L., and Sonsalla P.K. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 79 (2001) 152-160
17. Gotz M.E., Freyberger A., and Riederer P. Oxidative stress: a role in the pathogenesis of Parkinson's disease. J Neural Transm Suppl 29 (1990) 241-249
18. Gotz M.E., Kunig F., Riederer P., and Youdim M.B.H. Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63 (1994) 37-122
19. Granado N., O'Shea E., Bove J., Vila M., Colado M.I., and Moratalla R. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. J Neurochem 107 (2008) 1102-1112
20. Gudelsky G.A., and Yamamoto B.K. MDMA increases the extracellular concentration of 2,3-dihydrobenzoic acid in the striatum: evidence for increased hydroxyl radical formation. Abstr Soc Neurosci 20 (1994) 1026
21. Haile C.N., GrandPre T., and Kotsen T.A. Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats. Psychopharm 154 (2001) 213-220
22. Haney M., Maccar S., LeMoal M., Simon H., and Piazza P.V. Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res 698 (1995) 46-52
23. Herman J.P., Sinus L., and LeMoal M. Repeated stress increases locomotor response to amphetamine. Psychopharmacology 84 (1984) 431-435
24. Herman J.P., Adams D., and Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 61 (1995) 180-190
25. Holsboer F. The stress hormone system is back on the map. Curr Psychiatry Rep 2 (2000) 454-456
26. Johnson M., Stone D.M., Bush L.G., Hanson G.R., and Gibb J.W. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. Eur J Pharmacol 161 (1989) 181-188
27. Kashihara K., Hamamura T., Okumura K., and Otsuki S. Methamphetamine-induced dopamine release in the medial frontal cortex of freely moving rats. Jpn J Psychiatry Neurol 45 (1991) 677-680
28. Koenig J.I., Gudelsky G.A., and Meltzer H.Y. Simulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 137 (1987) 1-8
29. Koob G.F., and LeMoal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
30. LaVoie M.J., and Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19 (1999) 1484-1491
31. Lawrence M.S., and Sapolsky R.M. Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Res 646 (1994) 303-306
32. Lin M.T., Tsay H.J., Su W.H., and Chueh F.Y. Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function. Am J Physiol 274 (1998) R1260-R1267
33. Logan B.J., Laverty R., Sanderson W.D., and Yee Y.B. Differences between rats and mice in MDMA (methylenedioxymethamphetamine) neurotoxicity. Eur J Pharmacol 152 (1988) 227-234
34. Madrigal J.L.M., Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Rodrigo J., and Leza J.C. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24 (2001) 420-429
35. Magarinos A.M., and McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparisons of stressors. Neuroscience 69 (1995) 83-88
36. Magarinos A.M., and McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69 (1995) 89-98
37. Malberg J.E., and Seiden L.S. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18 (1998) 5086-5094
38. Marinelli M., and Piazza P.V. Interaction between glucocorticoid hormones, stress, and psychostimulant drugs. Eur J Neurosci 16 (2002) 387-394
39. Matuszewich L., and Yamamoto B.K. Long-lasting effects of chronic stress on DOI-induced hyperthermia. Psychopharmacology 169 (2003) 169-175
40. Matuszewich L., and Yamamoto B.K. Chronic stress augments the long-term and acute effects of methamphetamine. Neuroscience 124 (2004) 637-646
41. McEwen B.S., and Sapolsky R.M. Stress and cognitive function. Curr Opin Neurobiol 5 (1995) 205-216
42. McEwen B.S. Stress, adaptation, and disease. Ann N Y Acad Sci 840 (1998) 33-41
43. McIntosh J.L., and Sapolsky R.M. Glucocorticoids increase the accumulation of reactive oxygen species and enhance Adriamycin-induced toxicity in neuronal culture. Exp Neurol 141 (1996) 201-206
44. McIntosh J.L., Hong K.E., and Sapolsky R.M. Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies. Brain Res 791 (1998) 209-214
45. Mechanick J.I., Cohen-Becker I.R., Gregerson K.A., and Selmanoff M. Distribution of 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylglycol (DOPEG) in microdissected brain structures and the pituitary gland: metabolite changes in the median eminence in response to hyperprolactinemia and suckling. J Neural Transm 68 (1987) 197-215
46. Munck A., Guyre P.M., and Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5 (1984) 25-44
47. Najavits L.M., Gastfriend D.R., Barber J.P., Reif S., Muenz L.R., Blaine J., Frank A., Crits-Christoph P., Thase M., and Weiss R.D. Cocaine dependence with and without PTSD among subjects in the National Institute of Drug Abuse Collaborative Cocaine Treatment study. Am J Psychiatry 155 (1998) 214-219
48. Nash J.F., Meltzer H.Y., and Gudelsky G.A. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245 (1988) 873-879
49. Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Fernandez A.P., Rodrigo J., Bosca L., and Leza J.C. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 74 (2000) 785-791
50. Ossowska G., Nowak G., Kata R., Klenk-Majewska B., Danilczuk Z., and Zebrowska-Lupina I. Brain monoamine receptors in a chronic unpredictable stress model in rats. J Neural Transm 108 (2001) 311-319
51. Piazza P.V., Deminiere J.M., Le Moal M., and Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514 (1990) 22-26
52. Piazza P.V., and LeMoal M. The role of stress in drug self-administration. Trends Pharmacol Sci 19 (1998) 67-74
53. Reneman L., Booij J., de Bruin K., Reitsma J.B., de Wolff F.A., Boudewijn Gunning W., den Heeten G.J., and van den Brink W. Effects of dose, sex and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358 (2001) 1864-1869
54. Reul J.M., and de Kloet E.R. Two receptor systems of corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985) 2505-2511
55. Rhoads D.L. A longitudinal study of life stress and social support among drug abusers. Int J Addict 18 (1983) 195-222
56. Ricaurte G.A., Schuster C.R., and Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193 (1980) 153-163
57. Ricaurte G.A., Forno L.S., Wilson M.A., DeLanney L.E., Irwin I., Molliver M.E., and Langston J.W. (±)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in non-human primates. JAMA 206 (1988) 51-55
58. Sabol K.E., Lew R., Richards J.B., Vosmer G.L., and Seiden L.S. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. J Pharmacol Exp Ther 276 (1996) 846-854
59. Salmi P., and Ahlenius S. Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms. Pharmacol Toxicol 82 (1998) 122-127
60. Sapolsky R.M. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J Neurosci 5 (1985) 1228-1232
61. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus: temporal aspects of neuronal vulnerability. Brain Res 359 (1985) 300-305
62. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, MDMA. J Pharmacol Exp Ther 240 (1987) 1-7
63. Schmidt C.J., and Taylor V.L. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol 36 (1987) 4095-5102
64. Shalev U., Marinelli M., Baumann M.H., Piazza P.V., and Shaham Y. The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat. Psychopharmacology 168 (2003) 170-176
65. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. J Neurochem 72 (1999) 2516-2522
66. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse 40 (2001) 55-64
67. Sheard M.H., and Aghajanian G.K. Neural release of brain serotonin and body temperature. Nature 216 (1967) 495-496
68. Sonino N. Inhibition of adrenal steroid Biosynthesis by metyrapone. In: Agarwal M.K. (Ed). Hormone antagonists (1982), Walter de Gruyter & Co, Berlin 419-429
69. Sonsalla P.K., Nicklas W.J., and Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243 (1989) 398-400
70. Sonsalla P.K., Albers D.S., and Zeevalk G.D. Role of glutamate in neurodegeneration of dopamine neurons in several models of Parkinsonism. Amino Acids 14 (1998) 69-74
71. Steele T.D., McCann U.D., and Ricaurte G.A. 3,4-Metyylenedioxymethamphetamine (MDMA, "ecstasy"): pharmacology and toxicology in animals and humans. Addiction 89 (1994) 539-551
72. Stephans S.E., and Yamamoto B.K. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res 700 (1995) 99-106
73. Stone D.M., Stahl D.C., Hanson G.R., and Gibb J.W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128 (1986) 41-48
74. Stone D.M., Merchant K.M., Hanson G.R., and Gibb J.W. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26 (1987) 1677-1683
75. Tata D.A., Raudensky J., and Yamamoto B.K. Augmentation of methamphetamine-induced toxicity in rat striatum by unpredictable stress: contribution of enhanced hyperthermia. Eur J Neurosci 26 (2007) 739-748
76. Woolley C.E., Gould E., and McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 531 (1990) 225-231
77. Yamamoto B.K., and Spanos L.J. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148 (1988) 195-203
78. Zhang Y., Damjanoska K.J., Carrasco G.A., Dudas B., D'Souza D.N., Tetxlaff J., Garcia F., Hanley N.R., Scripathirathan K., Peterson B.R., Gray T.S., Battaglia G., Muma N.A., and Van de Kar L.D. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J Neurosci 22 (2002) 9635-9642